Tonix Pharmaceuticals Holding Corp. Gains 92.22%
Thu, Feb 27, 2020 at 05:30 PM
Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ) soared at $1.73, representing a gain of 92.2%. On Wed 26 Feb 20, TNXP:NASDAQ hit a New 2-Week High of $0.9. The stock appeared on our News Catalysts scanner on Thu 27 Feb 20 at 01:45 PM in the 'PATNERSHIP' category. From Wed 05 Feb 20, the stock recorded 14.29% Up Days and 33.33% Green Days
About Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ)
Tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company dedicated to the development of pharmaceutical products to address public health challenges. Its drug development program is focused on delivering treatment for PTSD.
Top 10 Gainers:
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 321.74%
- iBio, Inc. (IBIO:NYSEMKT), 158.98%
- Alpha Pro Tech, Ltd. (APT:NYSEMKT), 103.79%
- Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ), 92.22%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 79.33%
- Vir Biotechnology, Inc. (VIR:NASDAQ), 72.12%
- GAIN Capital Holdings, Inc. (GCAP:NYSE), 66.01%
- Aethlon Medical, Inc. (AEMD:NASDAQ), 58.73%
- Guardion Health Sciences, Inc. (GHSI:NASDAQ), 54.05%
- Vaxart, Inc. (VXRT:NASDAQ), 49.7%